| dc.contributor.author | Kirumbi, L W. | |
| dc.contributor.author | Maina, F W | |
| dc.contributor.author | Kigondu, S | |
| dc.contributor.author | Mati, J K | |
| dc.date.accessioned | 2013-05-24T07:00:51Z | |
| dc.date.available | 2013-05-24T07:00:51Z | |
| dc.date.issued | 1988 | |
| dc.identifier.citation | Master Of Medicine In Obstetrics And Gynaecology | en |
| dc.identifier.uri | http://erepository.uonbi.ac.ke:8080/xmlui/handle/11295/25124 | |
| dc.identifier.uri | http://www.ncbi.nlm.nih.gov/pubmed/12316812 | |
| dc.description.abstract | The effects of the triphasic oral Contraceptive (Ethinylestradiol (EE) and Levonorgesterol (LNG)) on lipid and lipoprotein metabolism was evaluated in ninety-seven black Kenyan women. Subjects were recruited between June 1984 and May 1985 and they were followed up for twelve months. There was an increase in fastlng levels of total cholesterol (TC), low-density lipoprotein cholesterol (LDL-c) and very low density lipoprotein cholesterol (VLDL-c). These changes were not statistically significant. However, the triglyceride increase was statistically significant
at nine months and twelve months (p< 0.05). The high density
lipoprotein cholesterol remained unchanged. This triphasic oral contraceptive was found to have minimal effect on the lipid and lipoprotein metabolism. | en |
| dc.language.iso | en | en |
| dc.publisher | University Of Nairobi | en |
| dc.title | Effects Of The Triphasic Oral Contraceptive On Lipid And Lipoprotein Metabolism | en |
| dc.type | Thesis | en |
| dc.description.department | a
Department of Psychiatry, University of Nairobi, ; bDepartment of Mental Health, School of Medicine,
Moi University, Eldoret, Kenya | |
| local.publisher | Department of Medicine | en |
